Found: 8
Select item for more details and to access through your institution.
Dopamine-induced changes to thalamic GABA concentration in impulsive Parkinson disease patients.
- Published in:
- NPJ Parkinson's Disease, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41531-022-00298-8
- By:
- Publication type:
- Article
Amphetamine-induced dopamine release and impulsivity in Parkinson's disease.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Accentuated Paralimbic and Reduced Mesolimbic D<sub>2/3</sub>-Impulsivity Associations in Parkinson's Disease.
- Published in:
- Journal of Neuroscience, 2023, v. 43, n. 50, p. 8733, doi. 10.1523/JNEUROSCI.1037-23.2023
- By:
- Publication type:
- Article
Elevated cerebral blood flow in patients with pure autonomic failure.
- Published in:
- Clinical Autonomic Research, 2021, v. 31, n. 3, p. 405, doi. 10.1007/s10286-021-00792-8
- By:
- Publication type:
- Article
The Role of a Dopamine-Dependent Limbic–Motor Network in Sensory Motor Processing in Parkinson Disease.
- Published in:
- Journal of Cognitive Neuroscience, 2023, v. 35, n. 11, p. 1806, doi. 10.1162/jocn_a_02048
- By:
- Publication type:
- Article
D²-Like Receptor Expression in the Hippocampus and Amygdala Informs Performance on the Stop-Signal Task in Parkinson's Disease.
- Published in:
- Journal of Neuroscience, 2021, v. 41, n. 48, p. 10023, doi. 10.1523/JNEUROSCI.0968-21.2021
- By:
- Publication type:
- Article
An Exploratory Pilot Study of Neuropsychological Performance in Two Huntington Disease Centers of Excellence Clinics.
- Published in:
- Archives of Clinical Neuropsychology, 2024, v. 39, n. 1, p. 24, doi. 10.1093/arclin/acad054
- By:
- Publication type:
- Article
Symptoms of Medication Withdrawal in Parkinson's Disease: Considerations for Informed Consent in Patient-Oriented Research.
- Published in:
- Pharmaceutical Medicine, 2021, v. 35, n. 3, p. 163, doi. 10.1007/s40290-021-00387-8
- By:
- Publication type:
- Article